Tofacitinib Citrate Tablets (JXHS2100011) Application for Marketing Technical Review Report

Update: 30 October, 2023

The text is the review report of the drug approval number, including indications, pharmacological toxicology evaluation, clinical pharmacology evaluation, efficacy evaluation, safety evaluation, risk analysis and control, benefit-risk evaluation, labeling review, technical conclusions, post-marketing requirements, and post-marketing risk control.

---

File format: PDF

Size: -

MD5 Checksum: F1BAF79D2658D5519C636A29E4F70412

Publication date: 30 October, 2023

Downloads: -

PDF Link: Tofacitinib Citrate Tablets (JXHS2100011) Application for Marketing Technical Review Report PDF